Glycated albumin demonstrates a convincing correlation with glycated hemoglobin levels in patients with type 2 diabetes mellitus. This indicator allows one to evaluate the state of carbohydrate metabolism, reflecting the average glucose level over a shorter period of time compared to glycated hemoglobin. Such ratio makes glycated albumin an important marker for monitoring the course of the disease, especially in cases where it is necessary to quickly respond to changes in blood glucose levels.

Glycated albumin, glycated hemoglobin, type 2 diabetes mellitus

Sources

Mihaela Ciobanu 1, Florina Bogdan 2, Cristina-Ioana Patruț 3, Gabriela Roman 1. Med Pharm Rep . 2019 Apr 25;92(2):134–138. doi: 10.15386/mpr-1247

Links

American Diabetes Association. Standards of Medical Care in Diabetes – 2016. Diabetes Care. 2016;39(Supplement1 ):S 1–S112. [Google Scholar]

Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and Recommendations for Laboratory Analysis in the Diagnostic and Management of Diabetes Mellitus. Clin Chem. 2011; 57:e 1–e47. doi: 10.1373/clinchem.2010.161596. [DOI] [PubMed] [Google Scholar]

Cavagnolli G, Pimentel AL, Freitas PA, Gross JL, Camargo JL. Factors affected by A1C in non-diabetic persons: Review and meta-analysis. Clin Chim Acta. 2015;445:107 –114. doi: 10.1016/j.cca.2015.03.024. [DOI] [PubMed] [Google Scholar]

Koga M. Glycosylated albumin; clinical utility. Clin Chim Acta. 2014;433:96–104 . doi: 10.1016/j.cca.2014.03.001. [DOI] [PubMed] [Google Scholar]

Furusyo N , Hayashi J. Glycosylated albumin and diabetes mellitus. Biochim Biophys Acta. 2013;1830:5509 –5514. doi: 10.1016/j.bbagen.2013.05.010. [DOI] [PubMed] [Google Scholar]

Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010;57:751 –762. doi: 10.1507/ endocrj.k 10e-138. [DOI] [PubMed] [Google Scholar]

Kosecki SM, Rodgers PT, Adams MB. Glycemic monitoring in diabetics with serpile cell plus beta-thalassemia hemoglobinopathy. Ann Pharmacother . 2005;39:1557 –1560. doi: 10.1345/aph.1G010. [DOI] [PubMed] [Google Scholar]

Freitas PAC, Ehlert LR, Camargo JL. Glycated albumin: a potential biomarker for diabetes. Arch Endocrinol Metab . 2017;61:296–304 . doi: 10.1590/2359-3997000000272. [DOI] [ Free PMC article ] [PubMed] [Google Scholar]

Paleari R, Bonetti G, Calla S, Carta M, Ceriotti F, Di Gaetano N, et al. Multicenter evaluation of an enzymatic glycated albumin assay. Clin Chim Acta. 2017;469: 81–86. doi: 10.1016/j.cca.2017.03.028. 10. Koga M, Suzuki S, Matsuo K, Tanahashi Y, Azuma H, Kasayama S. Calculation of HbA1c and glycated albumin from serial self-monitoring of blood glucose in patients with type 1 diabetes mellitus. Clin Chim Acta. 2013;425:188–191 . doi: 10.1016/j.cca.2013.07.029. [DOI] [PubMed] [Google Scholar] DOI ] [PubMed] [ Google Scholar ]

Nathan DM, McGee P, Steffes MW, Lachin JM DCCT/EDIC Research Group. Association of glycated albumin with blood glucose and HbA 1c levels and with retinopathy, nephropathy, and cardiovascular outcomes in the DCCT / EDIC study . Diabetes. 2014;63: 282–290. doi : 10.2337/ db 13-0782. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]

Testa R, Ceriotti F, Guerra E, Bonfigli AR, Boemi M, Cucchi M, et al . Glycated albumin: correlation with HbA1c and preliminary estimation of the reference interval . Clin Chem Lab Med . 2017; 55: e 31– e 33. doi : 10.1515/ cclm -2016-0512. [DOI] [PubMed] [Google Scholar]

Koga M , Murai J , Morita S , Saito H , Kasayama S. Comparison of annual variability of HbA 1c and glycated albumin in patients with type 1 and type 2 diabetes mellitus. J Diabetes Complications. 2013;27:211–213 . doi: 10.1016/j.jdiacomp.2012.12.001. [DOI] [PubMed] [Google Scholar]

Mo Y, Ma X, Li H, Ran X, Yang W, Li Q, et al . Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: a multicenter study. Diabetes Res Clin Pract . 2016;115:17 –23. doi :10.1016/ j . diabres.2016.03.003 . [DOI] [PubMed] [Google Scholar]

Sato Y, Nagao M, Asai A, Nakajima Y, Takaya M, Takeichi N, et al . Association of glycated albumin with the presence of carotid plaque in patients with type 2 diabetes. J Diabetes Investig . 2013;4:634–639 . doi : 10.1111/ jdi .12085. [DOI] [PMC free article ] [PubMed] [Google Scholar]

Gan T , Liu X , Xu G. Glycated albumin versus HbA 1c in assessing glycemic control in patients with diabetes and CKD. Kidney Int Rep. 2017;3:542–554 . doi: 10.1016/j.ekir.2017.11.009. [DOI] [ free PMC article ] [PubMed] [Google Scholar]

Huang Y , Hu Y , Ma YU , Ye G. Glycated albumin is an optimal biomarker gestational diabetes mellitus. Exp Ther Med. 2015;10:2145–2149 . doi: 10.3892/etm.2015.2808. [DOI] [ free PMC article ] [PubMed] [Google Scholar]

Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The impact of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med . 1993;329:977 –986. doi : 10.1056/ NEJM 199309303291401. [DOI] [PubMed] [Google Scholar]